Phase III Trial of Extended Temozolomide in Newly Diagnosed Glioblastoma

  • Parakh, Sagun (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/18/MH/154 (ERM Project ID 38427)
NMA SSA Reference Number: SSA/38427/MonH-2019-170798(v1)
Monash Health Ref: RES-19-0000-279X
StatusFinished
Effective start/end date20/05/19 → 19/05/24

Keywords

  • clinical trial
  • brain cancer
  • treatment efficacy